Eritadenine: Difference between revisions
No edit summary |
Add: year, pages, issue, volume, journal, title, author pars. 1-4. Formatted dashes. | You can use this tool yourself. Report bugs here. |
||
Line 28: | Line 28: | ||
}} |
}} |
||
'''Eritadenine''' is |
'''Eritadenine''' is a chemical compound found in [[shiitake]] mushrooms. Eritadenine is an inhibitor of [[S-adenosyl-L-homocysteine hydrolase]] (SAHH) and has hypocholesterolemic activity.{{cn}} |
||
==Synthesis== |
==Synthesis== |
||
The structure is a purine alkylated with an oxidized sugar fragment. |
The structure is a purine alkylated with an oxidized sugar fragment. |
||
[[File:Eritadenine synthesis.svg|thumb|center|700px|Eritadenine synthesis:<ref>{{cite journal | doi=10.1016/S0040-4039(01)88795-5 }}</ref> Alternative synthesis:<ref>{{cite journal | doi=10.1002/jhet.5570090230 }}</ref>]] |
[[File:Eritadenine synthesis.svg|thumb|center|700px|Eritadenine synthesis:<ref>{{cite journal | doi=10.1016/S0040-4039(01)88795-5 | title=Structure and synthesis of lentysine, a new hypocholesterolemic substance | journal=Tetrahedron Letters | volume=10 | issue=53 | pages=4729–4732 | year=1969 | last1=Kamiya | first1=T. | last2=Saito | first2=Y. | last3=Hashimoto | first3=M. | last4=Seki | first4=H. }}</ref> Alternative synthesis:<ref>{{cite journal | doi=10.1002/jhet.5570090230 | title=Hypocholesterolemic alkaloids of lentinus edodes (berk.) sing. II. A novel synthesis of eritadenine | journal=Journal of Heterocyclic Chemistry | volume=9 | issue=2 | pages=359–362 | year=1972 | last1=Kamiya | first1=T. | last2=Saito | first2=Y. | last3=Hashimoto | first3=M. | last4=Seki | first4=H. }}</ref>]] |
||
Ring opening of the protected lactone ('''1'''), derived from [[erythrose]] with [[sodium phthalimide]] gives the acid '''2'''; hydrazinolysis (cf [[Gabriel synthesis]]) then leads to the amino acid '''3'''. Displacement of chlorine in [[pyrimidine]] '''4''' by the amine function on '''3''' serves to attach the future imidazole nitrogen and the sugar-derived sidechain ('''5'''). The nitro group is then reduced by catalytic hydrogenation, the resulting primary amine is the most basic and is selectively formylated with [[formic acid]]. These strongly acidic conditions serve to remove the acetonide protecting group as well ('''6'''). Treatment with NaOH then serves to close the imidazole ring, forming eritadenine ('''7''') |
Ring opening of the protected lactone ('''1'''), derived from [[erythrose]] with [[sodium phthalimide]] gives the acid '''2'''; hydrazinolysis (cf [[Gabriel synthesis]]) then leads to the amino acid '''3'''. Displacement of chlorine in [[pyrimidine]] '''4''' by the amine function on '''3''' serves to attach the future imidazole nitrogen and the sugar-derived sidechain ('''5'''). The nitro group is then reduced by catalytic hydrogenation, the resulting primary amine is the most basic and is selectively formylated with [[formic acid]]. These strongly acidic conditions serve to remove the acetonide protecting group as well ('''6'''). Treatment with NaOH then serves to close the imidazole ring, forming eritadenine ('''7''') |
||
Line 41: | Line 41: | ||
* [https://www.ncbi.nlm.nih.gov/pubmed/17214973 Structure and function of eritadenine and its 3-deaza analogues] |
* [https://www.ncbi.nlm.nih.gov/pubmed/17214973 Structure and function of eritadenine and its 3-deaza analogues] |
||
[[Category: |
[[Category:Alkaloids]] |
||
[[Category: |
[[Category:Carboxylic acids]] |
||
{{organic-chem-stub}} |
Revision as of 22:49, 18 June 2019
Names | |
---|---|
IUPAC name
(2R,3R)-4-(6-Aminopurin-9-yl)-2,3-dihydroxybutanoic acid
| |
Other names
Lentysine; Lentinacin
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C9H11N5O4 | |
Molar mass | 253.218 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Eritadenine is a chemical compound found in shiitake mushrooms. Eritadenine is an inhibitor of S-adenosyl-L-homocysteine hydrolase (SAHH) and has hypocholesterolemic activity.[citation needed]
Synthesis
The structure is a purine alkylated with an oxidized sugar fragment.
Ring opening of the protected lactone (1), derived from erythrose with sodium phthalimide gives the acid 2; hydrazinolysis (cf Gabriel synthesis) then leads to the amino acid 3. Displacement of chlorine in pyrimidine 4 by the amine function on 3 serves to attach the future imidazole nitrogen and the sugar-derived sidechain (5). The nitro group is then reduced by catalytic hydrogenation, the resulting primary amine is the most basic and is selectively formylated with formic acid. These strongly acidic conditions serve to remove the acetonide protecting group as well (6). Treatment with NaOH then serves to close the imidazole ring, forming eritadenine (7)
References
- ^ Kamiya, T.; Saito, Y.; Hashimoto, M.; Seki, H. (1969). "Structure and synthesis of lentysine, a new hypocholesterolemic substance". Tetrahedron Letters. 10 (53): 4729–4732. doi:10.1016/S0040-4039(01)88795-5.
- ^ Kamiya, T.; Saito, Y.; Hashimoto, M.; Seki, H. (1972). "Hypocholesterolemic alkaloids of lentinus edodes (berk.) sing. II. A novel synthesis of eritadenine". Journal of Heterocyclic Chemistry. 9 (2): 359–362. doi:10.1002/jhet.5570090230.